Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Field Trials to Efficacy of Natural Products for the Control of the Tick Vectors of Lyme Disease Spirochetes, Program Announcement (PA) CK08-001; Evaluation of Reservoir-Targeted Vaccine Formulations To Prevent Enzootic Transmission of Borrelia Burgdorferi (Lyme Borreliosis), PA CK08-002, 2257 [E8-480]

Download as PDF 2257 Federal Register / Vol. 73, No. 9 / Monday, January 14, 2008 / Notices No. of respondents Type of respondents Form name Supervisor/Manager of EMS Personnel .................................. Screening Script to Identify Supervisor for Interview. Local EMS Provider Survey ... Topic Guide for Semi-Structured Telephone Interview. Administrator/Director of Sub-state EMS Region ................... Dated: January 7, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–425 Filed 1–11–08; 8:45 am] BILLING CODE 4163–18–P Dated: January 8, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–480 Filed 1–11–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Field Trials to Efficacy of Natural Products for the Control of the Tick Vectors of Lyme Disease Spirochetes, Program Announcement (PA) CK08–001; Evaluation of Reservoir-Targeted Vaccine Formulations To Prevent Enzootic Transmission of Borrelia Burgdorferi (Lyme Borreliosis), PA CK08–002 rmajette on PROD1PC64 with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Privacy Act of 1974; Report of a Modified or Altered System of Records Correction: This notice was published in the Federal Register on December 19, 2007, Volume 72, Number 243, page 71913–71914. The title and place should read as follows: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Field Trials to Efficacy of Natural Products for the Control of the Tick Vectors of Lyme Disease Spirochetes, Program Announcement (PA) CK08–001; Evaluation of Reservoir-Targeted Vaccine Formulations To Prevent Enzootic Transmission of Borrelia Burgdorferi (Lyme Borreliosis), PA CK08–002. Place: Teleconference. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 15:22 Jan 11, 2008 Jkt 214001 Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS). ACTION: Notice of a Modified or Altered System of Records (SOR). AGENCY: SUMMARY: In accordance with the Privacy Act of 1974, we are proposing to modify or alter an existing SOR, ‘‘Health Plan Management System (HPMS) ,’’ System No. 09–70–4004, established at 63 Federal Register 43187 (August 12, 1998). We will broaden the scope of this system by including a new activity related to health plan and Part D plan management referred to as the Complaint Tracking Module (CTM). CTM will collect and maintain identifiable information on individuals who are, but not limited to, complainants, including beneficiaries, relatives and caregivers, Congresspersons and their staff, State Health Insurance Program representatives, and providers of service and their staff. The CTM stores complaint data, including, but not limited to, the following: Date complaint received; date of incident; issue level; complainant and/or beneficiary information; complaint summary; complaint category; complaint resolution summary; and plan resolution summary. Plans use the CTM to track the beneficiary complaints assigned to their organization, enter complaint case resolutions, and close out complaints. In addition, HPMS will collect information from health plans and Part PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Average burden per response (in hours) No. of responses per respondent 2,250 1 2/60 1,800 10 1 1 15/60 45/60 D plan organizations pertaining to individuals who market and/or sell health insurance and prescription drug plan products on behalf of these plan organizations and who are licensed or authorized by a State Insurance Commissioner or other certifying agencies. We are sharing data pertaining to all agents/brokers to assist CMS and State Insurance Commissioners in improving oversight of the sales marketplace and in avoiding fraudulent sales practices that mislead and harm Medicare beneficiaries. We propose to assign a new CMS identification number to this system to simplify the obsolete and confusing numbering system originally designed to identify the Bureau, Office, or Center that maintained information in the Health Care Financing Administration systems of records. The new assigned identifying number for this system should read: System No. 09–70–0500. We will delete routine use number 1 authorizing disclosure to support constituent requests made to a congressional representative. If an authorization for the disclosure has been obtained from the data subject, then no routine use is needed. The Privacy Act allows for disclosures with the ‘‘prior written consent’’ of the data subject. We propose to delete published routine use number 5 authorizing disclosure to a contractor for the purpose of collating, analyzing, aggregating or otherwise refining or processing records in this system or for developing, modifying and/or manipulating automated information systems software. We also propose to add a routine use for the release of information that permits disclosure to agency contractors, consultants, and CMS grantees that perform a task for the agency. CMS occasionally contracts out certain of its functions when doing so would contribute to effective and efficient operations. CMS must be able to give a contractor, consultant or grantee whatever information is necessary for the contractor, consultant, or grantee to fulfill its duties. We propose to delete published routine use number 2 authorizing disclosure to the Bureau of Census; E:\FR\FM\14JAN1.SGM 14JAN1

Agencies

[Federal Register Volume 73, Number 9 (Monday, January 14, 2008)]
[Notices]
[Page 2257]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Field Trials to Efficacy of Natural Products for 
the Control of the Tick Vectors of Lyme Disease Spirochetes, Program 
Announcement (PA) CK08-001; Evaluation of Reservoir-Targeted Vaccine 
Formulations To Prevent Enzootic Transmission of Borrelia Burgdorferi 
(Lyme Borreliosis), PA CK08-002

    Correction: This notice was published in the Federal Register on 
December 19, 2007, Volume 72, Number 243, page 71913-71914. The title 
and place should read as follows:
    Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Field Trials to Efficacy of Natural Products for 
the Control of the Tick Vectors of Lyme Disease Spirochetes, Program 
Announcement (PA) CK08-001; Evaluation of Reservoir-Targeted Vaccine 
Formulations To Prevent Enzootic Transmission of Borrelia Burgdorferi 
(Lyme Borreliosis), PA CK08-002.
    Place: Teleconference.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: January 8, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-480 Filed 1-11-08; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.